Association between macular perfusion and photoreceptor layer status in diabetic macular edema

Retina

Volumn 35, Issue 2, 2015, Pages 288-293

  Benitez Herreros, Javier ^a   Lopez Guajardo, Lorenzo ^a,b   Camara Gonzalez, Cristina ^a   Vazquez Blanco, Miguel ^a   Castro Rebollo, María ^a  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

diabetic macular edema; external limiting membrane; foveal avascular zone; inner and outer segment junction band; inner segment ellipsoid band; macular perfusion; photoreceptor layer status

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ANGIOGRAPHY DEVICE; ARTICLE; ASSESSMENT OF HUMANS; BEST CORRECTED VISUAL ACUITY; COMPARATIVE STUDY; DIABETIC MACULAR EDEMA; FEMALE; FOVEAL AVASCULAR ZONE SIZE; HUMAN; MACULAR ANALYSIS; MACULAR PERFUSION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PERFUSION; PHOTORECEPTOR MEMBRANE; RETINA FLUORESCEIN ANGIOGRAPHY; SLIT LAMP; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS; BLOOD RETINA BARRIER; CAPILLARY PERMEABILITY; DIABETIC RETINOPATHY; FLUORESCENCE ANGIOGRAPHY; ISCHEMIA; MACULAR EDEMA; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHOTORECEPTOR CELL; PHYSIOLOGY; RETINA BLOOD VESSEL; RETROSPECTIVE STUDY;

BLOOD-RETINAL BARRIER; CAPILLARY PERMEABILITY; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISCHEMIA; MACULAR EDEMA; MALE; MIDDLE AGED; PHOTORECEPTOR CELLS, VERTEBRATE; RETINAL VESSELS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84922404414     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000299     Document Type: Article

References (33)

1. Bunce C, Wormald R. Causes of blind certifications in England andWales: April 1999-March 2000. Eye (Lond) 2008;22:905-911.
2. Paulus YM, Gariano RF. Diabetic retinopathy: a growing concern in an aging population. Geriatrics 2009;64:16-20.
3. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther 2008;88:1254-1264.
4. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997;14:1S-85S.
5. Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina 2011;31:1609-1619.
6. Spaide RF. Questioning optical coherence tomography. Ophthalmology 2012;119:2203-2204.
7. Murakami T, Nishijima K, Sakamoto A, et al. Association of pathomorphology, photoreceptor status, and retinal thickness with visual acuity in diabetic retinopathy. Am J Ophthalmol 2011;151:310-317.
8. Sakamoto A, Nishijima K, Kita M, et al. Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 2009;247:1325-1330.
9. Uji A, Murakami T, Nishijima K, et al. Association between hyperreflective foci in the outer retina, status of photoreceptor layer, and visual acuity in diabetic macular edema. Am J Ophthalmol 2012;153:710-717.
10. Otani T, Yamaguchi Y, Kishi S. Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina 2010;30:774-780.
11. Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res 2010;29:144-168.
12. Mehdizadeh M. Macular edema-ischemia makes a vicious cycle in diabetic retinopathy: role of retinal hipoxia in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 2008;246: 1203; author reply 1205-1207.
13. Lee DH, Kim JT, Jung DW, et al. The relationship between foveal ischemia and spectral-domain optical coherence tomography findings in ischemic diabetic macular edema. Invest Ophthalmol Vis Sci 2013;54:1080-1085.
14. Yeung L, Lima VC, Garcia P, et al. Correlation between spectral domain optical coherence tomography findings and fluorescein angiography patterns in diabetic macular edema. Ophthalmology 2009;116:1158-1167.
15. Bresnick GH, Condit R, Syrjala S, et al. Abnormalities of the foveal avascular zone in diabetic retinopathy. Arch Ophthalmol 1984;102:1286-1293.
16. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology 1984;91:1-9.
17. Shin HJ, Lee SH, Chung H, Kim HC. Association between photoreceptor integrity and visual outcome in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 2012;250:61-70.
18. Berne RM, Levy MN. Principles of Physiology. St Louis, MO: C. V. Mosby; 1990:470.
19. Soliman W, Sander B, Hasler PW, Larsen M. Correlation between intraretinal changes in diabetic macular oedema seen in fluorescein angiography and optical coherence tomography. Acta Opthalmol 2008;86:34-39.
20. Kang SW, Park CY, Ham DI. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 2004;137:313-322.
21. Bolz M, Ritter M, Schneider M, et al. A systematic correlation of angiography and high-resolution optical coherence tomography in diabetic macular edema. Ophthalmology 2009;116: 66-72.
22. Hee MR, Puliafito CA, Duker JS, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998;105:360-370.
23. Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 2002;22:759-767.
24. Tyrberg M, Ponjavic V, Lovestam-Adrian M. Multifocal electroretinogram (mfERG) in patients with diabetes mellitus and an enlarged foveal avascular zone (FAZ). Doc Ophthalmol 2008;117:185-189.
25. Dmuchowska DA, Krasnicki P, Mariak Z. Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy? Graefes Arch Clin Exp Ophthalmol 2014:252:731-738.
26. Sim DA, Keane PA, Zarranz-Ventura J, et al. The effects of macular ischemia on visual acuity in diabetic retinopathy. Invest Ophthalmol Vis Sci 2013;54:2353-2360.
27. Sim DA, Keane PA, Zarranz-Ventura J, et al. Predictive factors for the progression of diabetic macular ischemia. Am J Ophthalmol 2013;156:684-692.
28. Chung EJ, Roh MI, Kwon OW, Koh HJ. Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema. Retina 2008;28:957-963.
29. Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 2010;33:2399-2405.
30. Michaelides M, Kaines A, Hamilton RD, et al. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2 Ophthalmology 2010;117:1078-1086.
31. Papadopoulou DN, Medrinos E, Mangioris G, et al. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration. Ophthalmology 2009;116:1755-1761.
32. Nguyen WD, Shah SM, Khwaja AA, et al; READ-2 Study Group. Two-year outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2). Study Ophthalmol 2010;117;2146-2151.
33. Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-1077.